We are capable of preparing nucleotide and amino acid sequence listings as per the following:
- WIPO standard for the presentation of nucleotide and amino acid sequence listings in patent applications (ST.25)
- USPTO sequence rules under 37 C.F.R. §§1.821-.825 published on June 1, 1998, entitled “Requirements for Patent Application Containing Nucleotide Sequence and Amino Acid Disclosures” (see Federal Register 63:104, 29620-29643)
- Corresponding equivalent rules in other jurisdictions
We prefer to receive complete patent details for preparing cost effective sequence listings in PTO acceptable format. We advise our clients to claim only the key innovative sequences and mention all other relevant sequences in full specifications. Our experienced professionals support our clients in finalising relevant sequences that can be claimed / mentioned in the patent applications.